Concord Biotech Limited
NSE: CONCORDBIO | Information Technology
Market Fundamentals
Stock Intelligence & News
Concorde names Mark Garland president of new Glendale campus
Concorde names Mark Garland president of new Glendale campus
Read Full Analysis →Concord Biotech Limited
Concord Biotech Limited has informed the Exchange regarding 'Completion of Inspection by the Pharmacy and Poisons Board (PPB) from Kenya and the National Drug Authority (NDA) from Uganda at Unit-II formulation facility'. |SUBJECT: Updates
Read Full Analysis →Stock Picks Today: SBI, HDFC AMC, Nestle, Hero Moto, Kajaria, Syngene, Concord Biotech, And More On Brokerages' Radar
Brokerages' Radar
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Concord Biotech Limited
Concord Biotech Limited has informed the Exchange regarding Acquisition (including agreement to acquire) |SUBJECT: Acquisition (including agreement to acquire)-XBRL
Read Full Analysis →Concord Biotech Limited
Concord Biotech Limited has informed the Exchange about Acquisition |SUBJECT: Acquisition
Read Full Analysis →Concord Enviro Systems Limited
Pursuant to Reg 30 of SEBI(LODR), 2015 we wish to inform you that the Hon''ble National Company Law Tribunal has vide its order dated June 11, 2026 issued further directions in connection with the petition filed by the company under Sections 230 to 232 of the Companies Act, 2013 seeking approval of the Scheme of Arrangement between the Company and its Shareholders. |SUBJECT: Scheme of Arrangement
Read Full Analysis →Concord Biotech Limited
Concord Biotech Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →Concord Biotech Limited
Concord Biotech Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →Concord Biotech Limited
Concord Biotech Limited has informed the Exchange regarding 'Completion of ANVISA Inspection conducted by the Brazilian Health Regulatory Agency at the Limbasi API Manufacturing Facility'. |SUBJECT: Updates
Read Full Analysis →Concord Biotech Limited
Concord Biotech Secures Abbreviated New Drug Application (ANDA) Approval for Tofacitinib Tablets, 5 mg and 10 mg |SUBJECT: General Updates
Read Full Analysis →Get instant alerts when CONCORDBIO breaks news
Join investors who track Concord Biotech Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for CONCORDBIO?
CONCORDBIO is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Concord Biotech Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding CONCORDBIO to your custom watchlist.